The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Selifanova E.I.

I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Moscow, Russia

Makeeva M.K.

Tsentral'nyĭ nauchno-issledovatel'skiĭ institut stomatologii i cheliustno-litsevoĭ khirurgii Minzdrava Rossii, Moskva

Turkina A.Iu.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

Esayan M.S.

First Moscow State Medical University, Moscow, Russia

Oral health in patients with systemic sclerosis

Authors:

Selifanova E.I., Makeeva M.K., Turkina A.Iu., Esayan M.S.

More about the authors

Journal: Stomatology. 2019;98(3): 104‑108

DOI: 10.17116/stomat201998031104

Read: 7401 times

Contact the author
Table of contents

ORAL HEALTH IN PATIENTS WITH SYSTEMIC SCLEROSIS
ORAL HEALTH IN PATIENTS WITH SYSTEMIC SCLEROSIS

To cite this article:

Selifanova EI, Makeeva MK, Turkina AIu, Esayan MS. Oral health in patients with systemic sclerosis. Stomatology. 2019;98(3):104‑108. (In Russ.)
https://doi.org/10.17116/stomat201998031104

Подписка 2026 Стоматология (Stomatology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The aim of this study was to conduct literature review about oral manifestations of scleroderma. Systemic sclerosis is a multisystem autoimmune disorder characterized by widespread fibrosis, vascular alterations and inflammation. Systemic sclerosis mainly affects people in age from 30 to 50 years, but the onset of disease can occur in any age. The disturbance of microcirculation with the activation and proliferation of endothelium and smooth muscle cells plays an important role in pathogenesis of sclerodrma. These changes lead to sclerosis and fibrosis of various part in human body. Orofacial manifestations of scleroderma include: reduced mouth opening, widening of periodontal ligament, teleangiectasia, bone lesions. Systemic scleroderma is often accompanied by Sjogren’s syndrome. Oral manifestations of Sjogren’s syndrome are recurrent parotitis, angular cheilitis, xerostomia and multiple caries. Sjogren’s syndrome leads to negative impact on patients health and mental status. Orofacial manifestations of systemic sclerosis are still poorly known, that is why more researches should be made to improve dental treatment of patients with systemic sclerosis.

Authors:

Selifanova E.I.

I.M. Sechenov First Moscow State Medical University, Russian Ministry of Health, Moscow, Russia

Makeeva M.K.

Tsentral'nyĭ nauchno-issledovatel'skiĭ institut stomatologii i cheliustno-litsevoĭ khirurgii Minzdrava Rossii, Moskva

Turkina A.Iu.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova

Esayan M.S.

First Moscow State Medical University, Moscow, Russia

Close metadata

References:

  1. Grinin VM, Skvorcova AA. Faktory, vliyayushchie na porazhaemost zubov kariesom i ego oslozhnenij u bol’nyh revmatoidnym artritom. Ctomatologiya dlya vsekh. 2011;1:54:30-31. (In Russ.)
  2. Barer GM, Gurevich KG, Smirnyagina VV, Fabrikant EG. Ispolzovanie stomatologicheskih izmerenij kachestva zhizni. Stomatologiya dlya vsekh. 2006;2:4-7. (In Russ.)
  3. Ratcliff JL. Oral Pathogens affect Gut Inflammation and Systemic Diseases. Advances in Dentistry & Oral Health. 2017;6:1. https://doi.org/10.19080/adoh.2017.06.555679
  4. Martynova EA, Makeeva IM, Rozhnova EV. Polost rta kak lokalnaya ehkologicheskaya sistema. Stomatologiya. 2008;87:3:68-75. (In Russ.)
  5. Nasonov EL, Nasonova VA. Rheumatologia. Nacionalnoe rukovodstvo. M. 2008. (In Russ.)
  6. Ananyeva LP. Early systemic scleroderma: a current diagnostic algorithm (a lecture). Rheumatology Science and Practice. 2012;2:87-93. (In Russ.) https://doi.org/10.14412/1995-4484-2012-1279
  7. Grinin VM, Badalyan GD. Klinicheskie osobennosti patologii parodonta pri sistemnoj sklerodermii. Stomatologicheskij forum. 2004;1:15-17. (In Russ.)
  8. Shilova LN, Chernov AS, Trubenko YuA, Krasilnikov AN, Nekrasova SP, Levkina MV. Sindrom Rejno: Cliniko-immunologicheskie osobennosti pri raznyh variantah. Fundamentalnye issledovaniya. 2015;1-8:1712-1716; (In Russ.)
  9. Stryuk RI, Ermolina LM, Revmaticheskie bolezni. Rukovodstvo dlya vrachej. M.: Izdatelstvo BINOM; 2014. (In Russ.)
  10. Malahov AB, Davtyan VG, Geppe NA, Osminina MK. Sistemnaya sklerodermiya: sovremennye aspekty problemy. Consilium Medicum. 2008;8:62-68. (In Russ.)
  11. Aliko A, Alushi A, Tafai A, Leva F. Oral mucosa involvement in rheumanoid arthritis, systemic erythematosus and systemic sclerosis. Int Dent J. 2010;60:5:353-358. https://doi.org/10.1016/j.ijom.2011.02.026
  12. Gallaso D, Mazzuca S, Marigliano N. Algorithm for the Diagnosis of Scleroderma. Early Systemic Sclerosis: Definitions and diagnostic criteria. Italian Journal of Medicine. 2013;4:3. https://doi.org/10.4081/itjm.2010.167
  13. Medsger TA. Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29:255-273. https://doi.org/10.1016/s0889-857x(03)00023-1
  14. Peoples C, et.al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. Journal of Scleroderma and Related Disorders. 2016;2:1. https://doi.org/10.5301/jsrd.5000209
  15. Guseva NG. Systemic scleroderma is a multidisciplinary problem. Rheumatology Science and Practice. 2011;2:10-14. (In Russ.) https://doi.org/10.14412/1995-4484-2011-596
  16. Guseva NG. Sistemnaya sklerodermiya. M.: Medicina; 1993. (In Russ.)
  17. Grinin VM, Karakhanyan VT. The structure and clinical features of periodontal pathology in systemic scleroderma. Rossiskaya stomatologia. 2009;2:53-55. (In Russ.)
  18. Kolchanova NEh, Saharuk NA, Tihonovskaya IV. Ocenka stomatologicheskogo statusa i ocenka nalichiya odontogennoj infekcii u pacientov s dermatologicheskoj patologiej (psoriaz, ehkzema, sklerodermiya). Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta. 2012;11:3. (In Russ.)
  19. Kolchanova NEh, Saharuk NA, Tihonovskaya IV. Ocenka stomatologicheskogo statusa i ocenka nalichiya odontogennoj infekcii u pacientov s dermatologicheskoj patologiej (psoriaz, ehkzema, sklerodermiya). Vestnik Vitebskogo gosudarstvennogo medicinskogo universiteta. 2012;11:3.
  20. Lukinyh LM, Zhulev EN, Chuprunova IN. Bolezni parodonta. Nizhnij Novgorod: NGMA; 2005. (In Russ.)
  21. Bazikyan EhA, Grinin VM, Badalyan GD. Hirurgicheskie aspekty pri lechenii patologii parodonta u bolnyh sistemnoj sklerodermiej. Stomatologiya dlya vsekh. 2004;3:26-28. (In Russ.)
  22. Obrazcov YuL. Stomatologicheskoe zdorove: sushchnost, znachenie dlya kachestva zhizni, kriterii ocenki. Stomatologiya. 2006;4:41-43. (In Russ.)
  23. Shardina LA, Gan EYu, Shardin SA. Kachestvo zhizni i psihicheskoe sostoyanie pacientok s boleznyu Shegrena. Vestnik Uralskoj medicinskoj akademicheskoj nauki. 2013;4(46):79-83. (In Russ.)
  24. Berezne A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken). 2011;63:277-285. https://doi.org/10.1002/acr.20342
  25. Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M. Canadian Scleroderma Research Group. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum. 2009;61:966-973. https://doi.org/10.1002/art.24614
  26. Aline Lauria Pires Abrao, Caroline Menezes Santana, Ana Cristina Barreto Bezerra, Rivadávio Fernandes Batista de Amorim, Mariana Branco da Silva, Licia Maria Henrique da Mota, Denise Pinheiro Falcão. What rheumatologists should know about orofacial manifestations of autoimmune rheumatic diseases. Rev Bras Reumatol Engl Ed. 2016;56(5):441-450. Epub 2016 Mar 16. https://doi.org/10.1016/j.rbre.2016.02.006
  27. Alexandridis C, White SC. Periodontal ligament changes in patients with progressive systemic sclerosis. Oral Surg Oral Med. 1984. https://doi.org/10.1016/0030-4220(84)90375-x
  28. Baron M, Hudson M, Tatibouet S, Steele R, Lo E, Gravel S, Gyger G, El Sayegh T, Pope J, Fontaine A, Masetto A, Matthews D, Sutton E, Thie N, Jones N, Copete M, Kolbinson D, Markland J, Nogueira G, Robinson D, Fritzler M, Gornitsky M. Relationship between disease characteristics and orofacial manifestations in systemic sclerosis: Canadian Systemic Sclerosis Oral Health Study III. Arthritis Care Res (Hoboken). 2015;67(5):681-690. https://doi.org/10.1002/acr.22490
  29. Chu CH, Yeung CMK, Lai IA, Leung WK, Mok MY. Oral health of Chinese people with systemic sclerosis Clinical. Oral Investigations. 2011;15:6: 931-939. https://doi.org/10.1007/s00784-010-0472-0
  30. Derbi HA, Borromeo G. Scleroderma and the oral health implications. Advances in Dentistry & Oral Health. 2018;7:4. https://doi.org/10.19080/adoh.2018.07.555716
  31. Hadj Said M, Foletti JM, Graillon N, Guyot L, Chossegros C. Orofacial manifestations of scleroderma. A literature review. Rev Stomatol Chir Maxillofac Chir Orale. 2016;117(5):322-326. Epub 2016 Jul 27. Review. https://doi.org/10.1016/j.revsto.2016.06.003
  32. Hudson M, Steele R, Baron M. Canadian Scleroderma Research Group. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum. 2007;37:93-98. https://doi.org/10.1016/j.semarthrit.2007.01.005
  33. Jung S, Martin T, Schmittbuhl M, Huck O. The spectrum of orofacial manifestations in systemic sclerosis: a challenging management. Oral Dis. 2017;23(4):424-439. https://doi.org/10.1111/odi.12507
  34. Adilhanyan VA, Grinin VM, Simonova MV, Bulyakov RT, Tumasyan GS. Karioznye i nekarioznye porazheniya tkanej zubov u bolnyh revmatoidnym artritom. Rossijskij stomatologicheskij zhurnal. 2011;1:15-17. (In Russ.)
  35. Grigorev SS, Osyagina VA, Gimaeva ZS. Mineralnyj sostav tverdyh tkanej zubov u bolnyh s sindromom Shegrena. Problemy stomatologii. 2008;5:18-19. (In Russ.)
  36. Baron M, Hudson M, Dagenais M, Macdonald D, Gyger G, El Sayegh T, Pope J, Fontaine A, Masetto A, Matthews D, Sutton E, Thie N, Jones N, Copete M, Kolbinson D, Markland J, Nogueira-Filho G, Robinson D, Fritzler M, Wang M, Gornitsky M. Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study. Arthritis Care Res (Hoboken). 2016;68(5):673-680. https://doi.org/10.1002/acr.22739
  37. Isola G, Williams RC, Lo Gullo A, Ramaglia L, Matarese M, Iorio-Siciliano V, Cosio C, Matarese G Risk association between scleroderma disease characteristics, periodontitis, and tooth loss. Clinical Rheumatology. 2017; 36:12:2733-2274. https://doi.org/10.1007/s10067-017-3861-9
  38. Chatterjee S. Imaging of Systemic Sclerosis (Scleroderma). Contemporary Diagnostic Radiology. 2016;39:6:8. https://doi.org/10.1097/01.cdr.0000481822.63232.9a
  39. Detert J, Pischon N, Buttgeret F. Pathogenesis of parodontitis in rheumatic diseases. Rheumatol. 2010;69:2:109-112. https://doi.org/10.1007/s00393-009-0560-1
  40. Isola G, Williams RC, Lo Gullo A, Ramaglia L, Matarese M, Iorio-Siciliano V, Cosio C, Matarese G. Risk association between scleroderma disease characteristics, periodontitis, and tooth loss. Clinical Rheumatology. 2017; 36:12:2733-2274. https://doi.org/10.1007/s10067-017-3861-9
  41. Hudson M, Pope J, Mahler M, Tatibouet S, Steele R, Baron M, et al. Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis. Arthritis Res Ther. 2012;14:50. https://doi.org/10.1186/ar3763
  42. Hudson M, Steele R, Lu Y, Thombs BD, Baron M. Canadian Scleroderma Research Group. Work disability in systemic sclerosis. J Rheumatol. 2009;36:2481-2486. https://doi.org/10.3899/jrheum.081237
  43. Auluck A. Widening of periodontal ligament space and mandibular resorption in patients with systemic sclerosis. Dentomax Radiol. 2007;36:441-442. https://doi.org/10.1007/s00784-010-0472-0
  44. Mehra A. Periodontal space widening in patients with systemic sclerosis: a probable explanation. Dentomax Radiol. 2008;37:183. https://doi.org/10.1259/dmfr/13827970
  45. Scardina GA, Pizzigatti ME, Messina P. Periodontal microciculatory abnormaolities in patients with systemic sclerosis. J Periodontol. 2005;76:1991-1995. https://doi.org/10.1902/jop.2005.76.11.1991
  46. Dzhanaev TI, Simonova MV, Grinin VM, Carev VN. Mikrobiologicheskij sostav rotovoj zhidkosti u bolnyh revmatoidnym artritom, sochetayushchimsya s sindromom Shegrena. Kafedra. 2008;7:1:34-37.(In Russ.)
  47. Selifanova EI, Simonova MV, Platonova VV, Sevbitov AV. Bolezn i sindrom Shegrena, vozmozhnosti diagnostiki v usloviyah stomatologicheskoj poliklinike. Dental Forum. 2014;3:42-44. (In Russ.)
  48. Selifanova EI, Simonova MV. Odontogennaya infekciya i disbakterioz polosti rta pri sindrome i bolezni Shegrena. Dental Forum. 2009; 2. (In Russ.)
  49. Avouac J, Sordet C, Depinay C, Ardizonne M, Vacher-Lavenu MC, Sibilia J, et al. Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum. 2006;54:2243-2249. https://doi.org/10.1002/art.21922
  50. Juarez-Beltran M, Henry-Ruiz DR, Cardoso-Ramon JM, Criales-Cortes JL. Case report of lymphocytic interstitial pneumonia associated with Sjogren syndrome. Gac Med Mex. 2007;143(5):437. https://doi.org/10.12890/2018_000856
  51. Knaś M, Zalewska A, Waszkiewicz N, Szulimowska J, Dziezcioł J, Sierakowski S, Waszkiel D. Salivary: flow and proteins of the innate and adaptive immunity in the limited and diffused systemic sclerosis. J Oral Pathol Med. 2014;43(7):521-529. https://doi.org/10.1155/2017/4923769
  52. Kobak S, Oksel F, Aksu K, Kabasakal Y. The frequency of sicca symptoms and Sjogren’s syndrome in patients with systemic sclerosis. Int J Rheum Dis. 2013;16:88-92. https://doi.org/10.1111/j.1756-185x.2012.01810.x
  53. Moutsopoulos HM. Sjogren’s syndrome: a forty year scientific journey. J Autoimmun. 2014;51:1-9. https://doi.org/10.1016/j.jaut.2014.01.001
  54. Skopouli FN, Katsiougiannis S. How stress contributes to autoimmunity-lessons from Sjögren’s syndrome. 2017;182:14-23. https://doi.org/10.1016/j.clim.2017.05.001
  55. Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, Gottenberg JE, Mariette X. Sjogren’s syndrome is associated with and not secondary to systemic sclerosis. Rheumatology (Oxford). 2007;46(2):321-326. Epub 2006 Jul 28. Review. PMID: 16877466. https://doi.org/10.1093/rheumatology/kel252
  56. Peoples C, et al. Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. Journal of Scleroderma and Related Disorders. 2016;2:1. https://doi.org/10.5301/jsrd.5000209
  57. Poole JL, Brewer C, Rossie K, Good CC, Conte C, Steen V. Factors related to oral hygiene in persons with scleroderma. Int J Dent Hyg. 2015;3:13-17. https://doi.org/10.1111/j.1601-5037.2004.00108.x
  58. Vincent C, Agard C, Barbarot S, N’Guyen JM, Planchon B, Durant C, Pistorius MA, Dreno B, Ponge T, Stalder JF, Mercier JM, Hamidou M. Orofacial manifestations of systemic sclerosis: a study of 30 consecutive patients. Rev Med Interne. 2009;30(1):5-11. Epub 2008 Aug 30. French. https://doi.org/10.1016/j.revmed.2008.06.012
  59. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64:475-487. https://doi.org/10.1136/annrheumdis-2016-210571
  60. Tan K. Flemon. Systemic sclerosis: the susceptible host (genetics and environment). Rheumatic Disease Clinics of North America. 2003;29:2:211-237. https://doi.org/10.1016/s0889-857x(03)00015-2
  61. Toomayan G, Vinson E. Clinical image: Mandibular osteolysis secondary to systemic sclerosis. Arthritis & Rheumatism. 2009;6:3. https://doi.org/10.1002/art.24357
  62. Pizzo G, Scardina GA, Messina P. Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003;7:175-178. https://doi.org/10.1007/s00784-003-0216-5
  63. Vivino FB. Sjogren’s syndrome: Clinical aspects. Clinical Immunology. 2017;182:48-54. https://doi.org/10.1016/j.clim.2017.04.005
  64. Makeeva IM, Arakelyan MG. Kompleks lechebnyh i profilakticheskih meropriyatij u pacientov s suhostyu polosti rta. Farmateka. 2014;8:14 (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.